Bevacizumab for the treatment of nonsquamous non-small-cell lung cancer in Portugal: a retrospective, multicenter study

INTRODUCTION: Lung cancer is the leading cause of cancer-related mortality. In patients with nonsquamous non-small-cell lung cancer (NSCLC) stage IIIB/IV treatment with chemotherapy plus bevacizumab led to significant improvements in progression-free and median overall survival (OS). AIM: To report...

Descripción completa

Detalles Bibliográficos
Autores principales: Estevinho, Fernanda, Soares, Marta, Azevedo, Isabel, Queiroga, Henrique, Parente, Bárbara, Brito, Ulisses, Teixeira, Encarnação, Sotto-Mayor, Renato, Araújo, António
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308635/
https://www.ncbi.nlm.nih.gov/pubmed/22457603
http://dx.doi.org/10.2147/CMAR.S29672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308635/
https://www.ncbi.nlm.nih.gov/pubmed/22457603
http://dx.doi.org/10.2147/CMAR.S29672

Ejemplares similares